Tradestie Institutional Equity Comparison Engine

NURE vs REZ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NURE Overall Edge

NURE Captures Institutional Edge (1โ€“1 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuveen Short-Term REIT ETF (NURE) driven by superior Momentum & Technical while REZ counters with relative strength in Options & Structure. Fundamentally, NURE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus REZ at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NURE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against REZ sits in UNCLASSIFIED (12th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NURE N/M vs REZ N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner NURE
1Y +16.7% vs +12.6% ยท 52W Pos 86% vs 67%
Options & Structure Winner REZ
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (12th %ile IV)
NURE Cboe BZX
Nuveen Short-Term REIT ETF
Institutional Equity
$32.53
+0.42% 1D
Market Cap N/A
1M Return +6.38%
1Y Return +16.73%
Forward P/E N/M
Unified AI Score
39.5 / 100 SELL
Tech 29.0 Fund 33.0 Flow 50.0 Mom 11.1
REZ NYSE Arca
iShares Residential and Multisector Real Estate ETF
Institutional Equity
$94.27
+0.1% 1D
Market Cap N/A
1M Return +4.97%
1Y Return +12.64%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 39.0 Fund 39.0 Flow 50.0 Mom 31.7

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NURE +16.73% REZ +12.64% Spread: +4.09 pp (NURE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NURE TTM Op. Margin: N/A REZ TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NURE vs REZ. Trailing 12-month operating profitability (NURE N/A vs REZ N/A) and valuation multiples (NURE N/M vs REZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NURE (3) vs REZ (0)
Institutional Metric NURE REZ Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 86% ($27โ€“$33) 67% ($82โ€“$100) Stronger Trend NURE
Beta / 30D Volatility Risk Regime 0.26ฮฒ ยท 18% Vol 0.08ฮฒ ยท 22% Vol Lower Realized Risk NURE
Unified Institutional Score Composite Signal 39.5 / 100 (SELL) 38.3 / 100 (SELL) Higher Composite NURE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NURE vs REZ Buy Guide
NURE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NURE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
REZ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live REZ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NURE nor REZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.